{
  "id": "5e776db8835f4e4777000011",
  "type": "factoid",
  "question": "Which company sells the drug Afrezza since 2015?",
  "ideal_answer": "Afrezza has been marketed by Sanofi since February 2015.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/26222134"
  ],
  "snippets": [
    {
      "text": "In contrary, MannKind Corporation started developing its ultra-rapid-acting insulin Afrezza in a bold bid, probably by managing the issues in which Exubera was not successful. Afrezza has been marketed since February, 2015 by Sanofi after getting FDA approval in June 2014. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26222134",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "Sanofi"
}